HDAC9 and neuroblastoma: Interestingly, we found that the expression levels of MIF and DDT in the NB cell line, SH-SY5Y, were significantly reduced after treatment with vorinostat, thus suggesting that HDAC inhibitors may be a possible novel therapeutic approach for NB patients [57].